| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED |
|---|---|---|---|---|---|---|---|
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE | 730,353 | — | — | 0 | Apr 20, 2021 | Apr 22, 2021 ↗ |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE | 1,073,595 | — | — | 0 | Apr 20, 2021 | Apr 22, 2021 ↗ |
| RXRX RECURSION PHARMACEUTICALS, INC. | PURCHASE | 3,951,141 | — | — | 3,951,141 | Apr 20, 2021 | Apr 22, 2021 ↗ |
| RXRX RECURSION PHARMACEUTICALS, INC. | PURCHASE | 3,726,963 | — | — | 3,726,963 | Apr 20, 2021 | Apr 22, 2021 ↗ |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE | 5,941,120 | — | — | 0 | Apr 20, 2021 | Apr 22, 2021 ↗ |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE | 3,726,963 | — | — | 0 | Apr 20, 2021 | Apr 22, 2021 ↗ |
| RXRX RECURSION PHARMACEUTICALS, INC. | PURCHASE | 5,941,120 | — | — | 5,941,120 | Apr 20, 2021 | Apr 22, 2021 ↗ |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE | 3,220,788 | — | — | 0 | Apr 20, 2021 | Apr 22, 2021 ↗ |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE | 1,095,529 | — | — | 0 | Apr 20, 2021 | Apr 22, 2021 ↗ |
| RXRX RECURSION PHARMACEUTICALS, INC. | PURCHASE | 3,726,963 | — | — | 3,726,963 | Apr 20, 2021 | Apr 22, 2021 ↗ |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE | 3,771,996 | — | — | 0 | Apr 20, 2021 | Apr 22, 2021 ↗ |
| RXRX RECURSION PHARMACEUTICALS, INC. | PURCHASE | 3,951,141 | — | — | 3,951,141 | Apr 20, 2021 | Apr 22, 2021 ↗ |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE | 3,951,141 | — | — | 0 | Apr 20, 2021 | Apr 22, 2021 ↗ |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE | 3,726,963 | — | — | 0 | Apr 20, 2021 | Apr 22, 2021 ↗ |
| RXRX RECURSION PHARMACEUTICALS, INC. | PURCHASE | 5,941,120 | — | — | 5,941,120 | Apr 20, 2021 | Apr 22, 2021 ↗ |